Order Article Reprints

Ishikawa T, Takahashi K, Ikeda N, Kajimoto Y, Hagiya Y, Ogura S-i, Miyatake S-i, Kuroiwa T. Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors. Pharmaceutics. 2011; 3(3):615-635. https://doi.org/10.3390/pharmaceutics3030615

Ishikawa, Toshihisa, Kenkichi Takahashi, Naokado Ikeda, Yoshinaga Kajimoto, Yuichiro Hagiya, Shun-ichiro Ogura, Shin-ichi Miyatake, and Toshihiko Kuroiwa. 2011. "Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors" Pharmaceutics 3, no. 3: 615-635. https://doi.org/10.3390/pharmaceutics3030615

Ishikawa, T., Takahashi, K., Ikeda, N., Kajimoto, Y., Hagiya, Y., Ogura, S.-i., Miyatake, S.-i., & Kuroiwa, T. (2011). Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors. Pharmaceutics, 3(3), 615-635. https://doi.org/10.3390/pharmaceutics3030615